Myriad Genetics
MYGN
MYGN
264 hedge funds and large institutions have $2.22B invested in Myriad Genetics in 2018 Q4 according to their latest regulatory filings, with 31 funds opening new positions, 110 increasing their positions, 74 reducing their positions, and 50 closing their positions.
New
Increased
Maintained
Reduced
Closed
more repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
more funds holding in top 10
Funds holding in top 10: →
less ownership
Funds ownership: →
less funds holding
Funds holding: →
36% less capital invested
Capital invested by funds: $3.48B → $2.22B (-$1.26B)
38% less first-time investments, than exits
New positions opened: 31 | Existing positions closed: 50
57% less call options, than puts
Call options by funds: $2.43M | Put options by funds: $5.67M
Holders
264
Holding in Top 10
1
Calls
$2.43M
Puts
$5.67M
Top Buyers
| 1 | +$23.3M | |
| 2 | +$21.4M | |
| 3 | +$21M | |
| 4 |
FCM
Frontier Capital Management
Boston,
Massachusetts
|
+$18.8M |
| 5 |
Vanguard Group
Malvern,
Pennsylvania
|
+$15.6M |
Top Sellers
| 1 | -$67.5M | |
| 2 | -$17.9M | |
| 3 | -$15.3M | |
| 4 |
Caisse de Depot et Placement du Quebec (CDPQ)
Montreal,
Quebec, Canada
|
-$12.2M |
| 5 |
Deutsche Bank
Frankfurt Am Main Ge,
Germany
|
-$7.99M |